A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE). Am Heart J. 2008 Jan; 155(1):113.e1-8.

View in: PubMed

subject areas

Aged
Angioplasty, Balloon, Coronary
Benzenesulfonates
Cardiac Catheterization
Combined Modality Therapy
Coronary Angiography
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Electrocardiography
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Middle Aged
Myocardial Infarction
Piperazines
Probability
Reference Values
Risk Assessment
Salvage Therapy
Stroke Volume
Survival Rate
Treatment Outcome
Ventricular Function, Left

authors with profiles

Michael R. Zile